Publications by authors named "Leonard Lionnet"
Article Synopsis
- Cholinergic urticaria (CholU) is a common condition where symptoms like itchy hives arise from sweating, but existing treatments often fail to provide adequate control for patients.
- In a phase IIa trial, the new oral medication izuforant was tested on adults with CholU who didn't respond well to traditional antihistamines.
- Results showed that while izuforant did not significantly improve the primary measures of urticaria activity, it did lead to noticeable improvements in patient-reported severity assessments compared to placebo.
Objective: To assess patient-reported outcomes (PROs) in individuals with significant residual low-frequency hearing and severe-to-profound high-frequency sensorineural hearing loss (SNHL) who received the hybrid cochlear implant (CI).
Study Design: Prospective, multicenter, nonrandomized, single-arm repeated measures, single-subject design.
Setting: Tertiary centers, ambulatory care.